Summary
Causes of death, with special reference to cerebral haemorrhage, among 240 patients with pathologically verified Parkinson's disease were investigated using the Annuals of the Pathological Autopsy Cases in Japan from 1981 to 1985. The leading causes of death were pneumonia and bronchitis (44.1%), malignant neoplasms (11.6%), heart diseases (4.1%), cerebral infarction (3.7%) and septicaemia (3.3%). Cerebral haemorrhage was the 11th most frequent cause of death, accounting for only 0.8% of deaths among the patients, whereas it was the 5th most common cause of death among the Japanese general population in 1985. The low incidence of cerebral haemorrhage as a cause of death in patients with Parkinson's disease may reflect the hypotensive effect of levodopa and a hypotensive mechanism due to reduced noradrenaline levels in the parkinsonian brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aminoff MJ, Gross M, Laatz B, Vakil SD, Petrie A, Calne DB (1975) Arterial blood pressure in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1:73–77
Calne DB, Brennan J, Spiers ASD, Stern GM (1970) Hypotension caused by L-dopa. Br Med J 1:474–475
Farley IJ, Hornykiewicz O (1976) Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. In: Birkmayer W, Hornykiewicz O (eds) Advances in Parkinsonism. Editiones Roche, Basel, pp 178–185
Godwin-Austen RB, Tomlinson EB, Frears CC, Kok HWL (1969) Effects of L-dopa in Parkinson's disease. Lancet II:165–168
Hoehn MM (1983) Parkinsonism treated with levodopa: progression and mortality. J Neural Transm [Suppl] 19:253–264
Hoehn MM (1986) Parkinson's disease: progression and mortality. In: Yahr MD, Bergmann KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 457–461
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442
Iwasaki S, Hamaguchi K, Iwasaki A, Takakusagi M, Narabayashi Y (1989) Hypotensive effect of long-term levodopa in patients with Parkinson's disease. Eur Neurol (in press)
Kaye SB, Shaw KM, Ross EJ (1976) Bromocriptine and hypertension. Lancet I:1176–1177
Kosei Tokei Kyokai (1987) Kokumin Eisei No Doukou. J Health and Welfare Statistics (Tokyo) [Suppl] 34:46–76
Marttila RJ, Rinne UK, Siirtola T, Sonninen V (1977) Mortality of patients with Parkinson's disease treated with levodopa. J Neurol 216:147–153
Marttila RJ, Rinne UK, Sonninen V (1984) Levodopa in Parkinson's disease: effect on mortality. Acta Neurol Scand [Suppl] 69:45–48
Statistics and Information Department, Minister's Secretariat Ministry of Health and Welfare (ed) (1987) Health and Welfare Statistics in Japan. Health and Welfare Statistics Association, Tokyo, p 43
Statistics and Information Department, Minister's Secretariat Ministry of Health and Welfare (ed) (1987) Health and Welfare Statistics in Japan. Health and Welfare Statistics Association, Tokyo, p 57
Sved AF, Fernstrom JD (1979) Reduction in blood pressure in normal and spontaneously hypertensive rats by lergotrile mesylate. J Pharm Pharmacol 31:814–817
Takahashi K, Nishikawa S, Harada H (1981) Study of long prognosis of parkinsonian patients. In: Annual Report of the Research Committee of Degenerative CNS Diseases. The Ministry of Health and Welfare of Japan, Tokyo, pp 185–188
The Japanese Pathological Society (ed) (1983) Annual of the Pathological Autopsy Cases in Japan, vol 24. The Japanese Pathological Society, Tokyo
The Japanese Pathological Society (ed) (1984) Annual of the Pathological Autopsy Cases in Japan, vol 25. The Japanese Pathological Society, Tokyo
The Japanese Pathological Society (ed) (1985) Annual of the Pathological Autopsy Cases in Japan, vol 26. The Japanese Pathological Society, Tokyo
The Japanese Pathological Society (ed) (1986) Annual of the Pathological Autopsy Cases in Japan, vol 27. The Japanese Pathological Society, Tokyo
The Japanese Pathological Society (ed) (1987) Annual of the Pathological Autopsy Cases in Japan, vol 28. The Japanese Pathological Society, Tokyo
Tomonaga M, Yoshimura M, Tohgi H, Yamanouchi H (1981) Clinicopathological study on the Parkinson's disease of the aged: cause of death and complications. In: Annual Report of the Research Committee of Degenerative CNS Diseases. The Ministry of Health and Welfare of Japan, Tokyo, pp 175–179
Van den Buuse M, Versteeg DG, De Jong W (1986) Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat. Brain Res 368:69–78
Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM (1969) Treatment of parkinsonism with levodopa. Arch Neurol 21:343–354
Yen TT, Stamm NB, Clemens JA (1979) Pergolide: a potent dopaminergic antihypertensive. Life Sci 25:209–216
Zumstein H, Siegfried J (1976) Mortality among Parkinson patients treated with L-dopa combined with a decarboxylase inhibitor. Eur Neurol 14:321–327
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwasaki, S., Narabayashi, Y., Hamaguchi, K. et al. Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage. J Neurol 237, 77–79 (1990). https://doi.org/10.1007/BF00314665
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314665